Evidence map›Paper›PMID 41757165›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Shared and distinct phenotypic profiles among neurodevelopmental disorder genes.

Hermela Shimelis, Matthew T Oetjens, Bobbi McGivern, Zhancheng Zhang, Janelle E Stanton, Ian McSalley, Shiva Ganesan, Brenda M Finucane, Ingo Helbig, Christa L Martin and 2 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hermela ShimelisDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, United States.
Matthew T OetjensDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, United States.
Bobbi McGivernGeneDx, LLC, Gaithersburg, MD, United States.
Zhancheng ZhangGeneDx, LLC, Gaithersburg, MD, United States.
Janelle E StantonFlorida Institute for Pediatric Rare Diseases, Florida State University College of Medicine, Tallahassee, FL, United States.
Ian McSalleyDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Shiva GanesanDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Brenda M FinucaneDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, United States.
Ingo HelbigDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.ORCID 0000-0001-8486-0558
Christa L MartinDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, United States.
Scott M MyersDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, United States.
David H LedbetterFlorida Institute for Pediatric Rare Diseases, Florida State University College of Medicine, Tallahassee, FL, United States.

Funding

GENE DOSAGE IMBALANCE IN NEURODEVELOPMENTAL DISORDERSR01MH074090 · NIMH · GEISINGER CLINIC · PI David H. Ledbetter, CHRISTA LESE MARTIN · 2005 to 2026
$13.5M
Characterizing the spectrum of genomic and phenotypic variation in cerebral palsyR01HD104938 · NICHD · GEISINGER CLINIC · PI Scott Myers · 2022 to 2026
$3.4M
A computational phenotyping approach to characterize neurogenetic disordersR01NS131512 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Ingo Helbig · 2023 to 2026
$2.8M
Subgroup delineation in genetic epilepsies and developmental brain disordersR01NS127830 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Ingo Helbig · 2023 to 2026
$2.8M
NICHD NIH HHS R01 HD104938NIMH NIH HHS R01 MH074090NINDS NIH HHS R01 NS127830NINDS NIH HHS R01 NS131512
6 · The paper itself

Abstract

Rare pathogenic variants in many genes contribute to neurodevelopmental disorders (NDDs), including intellectual disability and/or global developmental delay (ID), autism spectrum disorder (ASD), epilepsy (EP), and cerebral palsy (CP). These conditions frequently co-occur and share genetic etiologies, yet the broader phenotypic effects and the extent of shared versus distinct genetic influences remain unclear. Here, we adopt a cross-disorder framework to examine NDD genes across four diagnostic categories, characterize gene-associated phenotypic profiles, and identify convergent pathways that help refine how pathogenic variants in these genes shapes clinical outcomes. Using a discovery cohort of 8,973 probands with disease-causing variants in 263 NDD genes, we performed phenotype-based gene clustering and identified six distinct gene clusters. These clusters reveal structured patterns of genetic overlap, showing that subsets of NDD genes preferentially contribute to specific disorder combinations of ID, ASD, EP, and CP. The largest gene cluster was characterized by ID, whereas the other five included one enriched for ASD and ID, two for EP and ID and two for CP and ID, each with significantly differing frequencies. In an independent validation cohort of 19,704 probands, five of the six clusters were replicated. Gene Ontology enrichment analyses revealed distinct biological processes in each cluster, suggesting that coherent molecular mechanisms underlie the differing NDD diagnostic profiles. Together these findings demonstrate that NDD genes fall into coherent clusters that consistently map onto characteristic phenotype profiles, providing a framework to inform future therapeutic strategies and support early prognostication for individuals with pathogenic variants in NDD genes.

Identifiers

PMID41757165
PMCPMC12934880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.